-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Sunshine Biopharma Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2020 to Q3 2024.
- Sunshine Biopharma Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $215K, a 426% increase year-over-year.
- Sunshine Biopharma Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $114K, a 72% decline year-over-year.
- Sunshine Biopharma Inc. annual Income Tax Expense (Benefit) for 2023 was $395K, a 69.4% increase from 2022.
- Sunshine Biopharma Inc. annual Income Tax Expense (Benefit) for 2022 was $233K.
- Sunshine Biopharma Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)